Active Pharmaceutical Ingredients/API Market - Forecast(2024 - 2030)
1. Active Pharmaceutical Ingredients/API Market - Overview
1.1 Definitions and Scope
2. Active Pharmaceutical Ingredients/API Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Active Pharmaceutical Ingredients/API Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Active Pharmaceutical Ingredients/API Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Active Pharmaceutical Ingredients/API Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Active Pharmaceutical Ingredients/API Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Active Pharmaceutical Ingredients/API Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Active Pharmaceutical Ingredients/API Market - By Type (Market Size -$Million / $Billion)
8.1 Introduction
8.2 Innovative Active Pharmaceutical Ingredients
8.3 Generic Active Pharmaceutical Ingredients
9. Active Pharmaceutical Ingredients/API Market - By Type of Manufacturer (Market Size -$Million / $Billion)
9.1 Introduction
9.2 Captive API Manufacturers
9.3 Merchant API Manufacturers
9.3.1 Merchant API Manufacturers Market, By Type
9.3.1.1 Merchant Innovative API Manufacturers
9.3.1.2 Merchant Generic API Manufacturers
9.3.2 Merchant API Manufacturers Market, By Type of Synthesis
9.3.2.1 Merchant Synthetic API Manufacturers
13.1 Active Pharmaceutical Ingredients/API Market - North America Segment Research
13.2 North America Market Research (Million / $Billion)
13.2.1 Segment type Size and Market Size Analysis
13.2.2 Revenue and Trends
13.2.3 Application Revenue and Trends by type of Application
13.2.4 Company Revenue and Product Analysis
13.2.5 North America Product type and Application Market Size
13.2.5.1 U.S
13.2.5.2 Canada
13.2.5.3 Mexico
13.2.5.4 Rest of North America
13.3 Active Pharmaceutical Ingredients/API- South America Segment Research
13.4 South America Market Research (Market Size -$Million / $Billion)
13.4.1 Segment type Size and Market Size Analysis
13.4.2 Revenue and Trends
13.4.3 Application Revenue and Trends by type of Application
13.4.4 Company Revenue and Product Analysis
13.4.5 South America Product type and Application Market Size
13.4.5.1 Brazil
13.4.5.2 Venezuela
13.4.5.3 Argentina
13.4.5.4 Ecuador
13.4.5.5 Peru
13.4.5.6 Colombia
13.4.5.7 Costa Rica
13.4.5.8 Rest of South America
13.5 Active Pharmaceutical Ingredients/API- Europe Segment Research
13.6 Europe Market Research (Market Size -$Million / $Billion)
13.6.1 Segment type Size and Market Size Analysis
13.6.2 Revenue and Trends
13.6.3 Application Revenue and Trends by type of Application
13.6.4 Company Revenue and Product Analysis
13.6.5 Europe Segment Product type and Application Market Size
13.6.5.1 U.K
13.6.5.2 Germany
13.6.5.3 Italy
13.6.5.4 France
13.6.5.5 Netherlands
13.6.5.6 Belgium
13.6.5.7 Denmark
13.6.5.8 Spain
13.6.5.9 Rest of Europe
13.7 Active Pharmaceutical Ingredients/API - APAC Segment Research
13.8 APAC Market Research (Market Size -$Million / $Billion)
13.8.1 Segment type Size and Market Size Analysis
13.8.2 Revenue and Trends
13.8.3 Application Revenue and Trends by type of Application
13.8.4 Company Revenue and Product Analysis
13.8.5 APAC Segment - Product type and Application Market Size
13.8.5.1 China
13.8.5.2 Australia
13.8.5.3 Japan
13.8.5.4 South Korea
13.8.5.5 India
13.8.5.6 Taiwan
13.8.5.7 Malaysia
13.8.5.8 Hong kong
13.8.5.9 Rest of APAC
13.9 Active Pharmaceutical Ingredients/API - Middle East Segment and Africa Segment Research
13.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
13.10.1 Segment type Size and Market Size Analysis
13.10.2 Revenue and Trend Analysis
13.10.3 Application Revenue and Trends by type of Application
13.10.4 Company Revenue and Product Analysis
13.10.5 Middle East Segment Product type and Application Market Size
13.10.5.1 Israel
13.10.5.2 Saudi Arabia
13.10.5.3 UAE
13.10.6 Africa Segment Analysis
13.10.6.1 South Africa
13.10.6.2 Rest of Middle East & Africa
14. Active Pharmaceutical Ingredients/API Market - Entropy
14.1 New product launches
14.2 M&A s, collaborations, JVs and partnerships
15. Active Pharmaceutical Ingredients/API Market - Industry / Segment Competition landscape Premium
15.1 Market Share Analysis
15.1.1 Market Share by Country- Top companies
15.1.2 Market Share by Region- Top 10 companies
15.1.3 Market Share by type of Application - Top 10 companies
15.1.4 Market Share by type of Product / Product category- Top 10 companies
15.1.5 Market Share at global level - Top 10 companies
15.1.6 Best Practises for companies
16. Active Pharmaceutical Ingredients/API Market - Key Company List by Country Premium
17. Active Pharmaceutical Ingredients/API Market Company Analysis
17.1 Market Share, Company Revenue, Products, M&A, Developments
17.2 Abbvie Inc
17.3 Boehringer Ingelheim
17.4 Bristol-Myers Squibb
17.8 Merck & Co , Inc
17.9 Novartis International Ag
17.10 Pfizer, Inc
17.11 Sanofi
17.12 Teva Pharmaceutical Industry Ltd
17.13 Company 12
17.14 Company 13 & More
18.1 Abbreviations
18.2 Sources
19. Active Pharmaceutical Ingredients/API Market - Methodology
19.1 Research Methodology
19.1.1 Company Expert Interviews
19.1.2 Industry Databases
19.1.3 Associations
19.1.4 Company News
19.1.5 Company Annual Reports
19.1.6 Application Trends
19.1.7 New Products and Product database
19.1.8 Company Transcripts
19.1.9 R&D Trends
19.1.10 Key Opinion Leaders Interviews
19.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Active Pharmaceutical Ingredients/API Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Active Pharmaceutical Ingredients/API Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Active Pharmaceutical Ingredients/API Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Active Pharmaceutical Ingredients/API Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Active Pharmaceutical Ingredients/API Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Active Pharmaceutical Ingredients/API Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Active Pharmaceutical Ingredients/API Market - By Type (Market Size -$Million / $Billion)
8.1 Introduction
8.2 Innovative Active Pharmaceutical Ingredients
8.3 Generic Active Pharmaceutical Ingredients
9. Active Pharmaceutical Ingredients/API Market - By Type of Manufacturer (Market Size -$Million / $Billion)
9.1 Introduction
9.2 Captive API Manufacturers
9.3 Merchant API Manufacturers
9.3.1 Merchant API Manufacturers Market, By Type
9.3.1.1 Merchant Innovative API Manufacturers
9.3.1.2 Merchant Generic API Manufacturers
9.3.2 Merchant API Manufacturers Market, By Type of Synthesis
9.3.2.1 Merchant Synthetic API Manufacturers
9.3.2.2 Merchant Biotech API Manufacturers
10. Active Pharmaceutical Ingredients/API Market - By Type of Synthesis (Market Size -$Million / $Billion)
10.1 Introduction
10.2 Synthetic Active Pharmaceutical Ingredients
10.2.1 Synthetic Active Pharmaceutical Ingredients Market, By Type
10.2.1.1 Innovative Synthetic APIs
10.2.1.2 Generic Synthetic APIs
10.3 Biotech Active Pharmaceutical Ingredients
10.3.1 Biotech Active Pharmaceutical Ingredients Market, By Type
10.3.1.1 Innovative Biotech APIs
10.3.1.2 Generic Biotech APIs
10.3.2 Biotech Active Pharmaceutical Ingredients Market, By Product
10.3.2.1 Monoclonal Antibodies
10.3.2.2 Hormones & Growth Factors
10.3.2.3 Cytokines
10.3.2.4 Fusion Proteins
10.3.2.5 Recombinant Vaccines
10.3.2.6 Therapeutic Enzymes
10.3.2.7 Blood Factors
10.3.3 Biotech Active Pharmaceutical Ingredients Market, By Expression System
10.3.3.1 Mammalian Expression Systems
10.3.3.2 Microbial Expression Systems
10.3.3.3 Yeast Expression Systems
10.3.3.4 Insect Expression Systems
10.3.3.5 Other Expression Systems
10.2 Synthetic Active Pharmaceutical Ingredients
10.2.1 Synthetic Active Pharmaceutical Ingredients Market, By Type
10.2.1.1 Innovative Synthetic APIs
10.2.1.2 Generic Synthetic APIs
10.3 Biotech Active Pharmaceutical Ingredients
10.3.1 Biotech Active Pharmaceutical Ingredients Market, By Type
10.3.1.1 Innovative Biotech APIs
10.3.1.2 Generic Biotech APIs
10.3.2 Biotech Active Pharmaceutical Ingredients Market, By Product
10.3.2.1 Monoclonal Antibodies
10.3.2.2 Hormones & Growth Factors
10.3.2.3 Cytokines
10.3.2.4 Fusion Proteins
10.3.2.5 Recombinant Vaccines
10.3.2.6 Therapeutic Enzymes
10.3.2.7 Blood Factors
10.3.3 Biotech Active Pharmaceutical Ingredients Market, By Expression System
10.3.3.1 Mammalian Expression Systems
10.3.3.2 Microbial Expression Systems
10.3.3.3 Yeast Expression Systems
10.3.3.4 Insect Expression Systems
10.3.3.5 Other Expression Systems
11. Active Pharmaceutical Ingredients/API Market - By Type of Drug (Market Size -$Million / $Billion)
11.1 Introduction
11.2 Prescription Drugs
11.3 Over-The-Counter Drugs
11.4 Active Pharmaceutical Ingredients Market, By Potency
11.4.1 Low-To-Moderate Potency Active Pharmaceutical Ingredients
11.4.2 Potent-To-Highly Potent Active Pharmaceutical Ingredients
11.2 Prescription Drugs
11.3 Over-The-Counter Drugs
11.4 Active Pharmaceutical Ingredients Market, By Potency
11.4.1 Low-To-Moderate Potency Active Pharmaceutical Ingredients
11.4.2 Potent-To-Highly Potent Active Pharmaceutical Ingredients
12. Active Pharmaceutical Ingredients/API Market - By Therapeutic Application (Market Size -$Million / $Billion)
12.1 Introduction
12.2 Communicable Diseases
12.3 Oncology
12.4 Pain Management
12.5 Cardiovascular Diseases
12.6 Diabetes
12.7 Respiratory Diseases
12.8 Other Therapeutic Applications
13. Active Pharmaceutical Ingredients/API- By Geography (Market Size -$Million / $Billion)12.2 Communicable Diseases
12.3 Oncology
12.4 Pain Management
12.5 Cardiovascular Diseases
12.6 Diabetes
12.7 Respiratory Diseases
12.8 Other Therapeutic Applications
13.1 Active Pharmaceutical Ingredients/API Market - North America Segment Research
13.2 North America Market Research (Million / $Billion)
13.2.1 Segment type Size and Market Size Analysis
13.2.2 Revenue and Trends
13.2.3 Application Revenue and Trends by type of Application
13.2.4 Company Revenue and Product Analysis
13.2.5 North America Product type and Application Market Size
13.2.5.1 U.S
13.2.5.2 Canada
13.2.5.3 Mexico
13.2.5.4 Rest of North America
13.3 Active Pharmaceutical Ingredients/API- South America Segment Research
13.4 South America Market Research (Market Size -$Million / $Billion)
13.4.1 Segment type Size and Market Size Analysis
13.4.2 Revenue and Trends
13.4.3 Application Revenue and Trends by type of Application
13.4.4 Company Revenue and Product Analysis
13.4.5 South America Product type and Application Market Size
13.4.5.1 Brazil
13.4.5.2 Venezuela
13.4.5.3 Argentina
13.4.5.4 Ecuador
13.4.5.5 Peru
13.4.5.6 Colombia
13.4.5.7 Costa Rica
13.4.5.8 Rest of South America
13.5 Active Pharmaceutical Ingredients/API- Europe Segment Research
13.6 Europe Market Research (Market Size -$Million / $Billion)
13.6.1 Segment type Size and Market Size Analysis
13.6.2 Revenue and Trends
13.6.3 Application Revenue and Trends by type of Application
13.6.4 Company Revenue and Product Analysis
13.6.5 Europe Segment Product type and Application Market Size
13.6.5.1 U.K
13.6.5.2 Germany
13.6.5.3 Italy
13.6.5.4 France
13.6.5.5 Netherlands
13.6.5.6 Belgium
13.6.5.7 Denmark
13.6.5.8 Spain
13.6.5.9 Rest of Europe
13.7 Active Pharmaceutical Ingredients/API - APAC Segment Research
13.8 APAC Market Research (Market Size -$Million / $Billion)
13.8.1 Segment type Size and Market Size Analysis
13.8.2 Revenue and Trends
13.8.3 Application Revenue and Trends by type of Application
13.8.4 Company Revenue and Product Analysis
13.8.5 APAC Segment - Product type and Application Market Size
13.8.5.1 China
13.8.5.2 Australia
13.8.5.3 Japan
13.8.5.4 South Korea
13.8.5.5 India
13.8.5.6 Taiwan
13.8.5.7 Malaysia
13.8.5.8 Hong kong
13.8.5.9 Rest of APAC
13.9 Active Pharmaceutical Ingredients/API - Middle East Segment and Africa Segment Research
13.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
13.10.1 Segment type Size and Market Size Analysis
13.10.2 Revenue and Trend Analysis
13.10.3 Application Revenue and Trends by type of Application
13.10.4 Company Revenue and Product Analysis
13.10.5 Middle East Segment Product type and Application Market Size
13.10.5.1 Israel
13.10.5.2 Saudi Arabia
13.10.5.3 UAE
13.10.6 Africa Segment Analysis
13.10.6.1 South Africa
13.10.6.2 Rest of Middle East & Africa
14. Active Pharmaceutical Ingredients/API Market - Entropy
14.1 New product launches
14.2 M&A s, collaborations, JVs and partnerships
15. Active Pharmaceutical Ingredients/API Market - Industry / Segment Competition landscape Premium
15.1 Market Share Analysis
15.1.1 Market Share by Country- Top companies
15.1.2 Market Share by Region- Top 10 companies
15.1.3 Market Share by type of Application - Top 10 companies
15.1.4 Market Share by type of Product / Product category- Top 10 companies
15.1.5 Market Share at global level - Top 10 companies
15.1.6 Best Practises for companies
16. Active Pharmaceutical Ingredients/API Market - Key Company List by Country Premium
17. Active Pharmaceutical Ingredients/API Market Company Analysis
17.1 Market Share, Company Revenue, Products, M&A, Developments
17.2 Abbvie Inc
17.3 Boehringer Ingelheim
17.4 Bristol-Myers Squibb
17.5 Eli Lilly And Company
17.6 F. Hoffmann-La Roche
17.7 Glaxosmithkline Plc17.8 Merck & Co , Inc
17.9 Novartis International Ag
17.10 Pfizer, Inc
17.11 Sanofi
17.12 Teva Pharmaceutical Industry Ltd
17.13 Company 12
17.14 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
18. Active Pharmaceutical Ingredients/API Market - Appendix18.1 Abbreviations
18.2 Sources
19. Active Pharmaceutical Ingredients/API Market - Methodology
19.1 Research Methodology
19.1.1 Company Expert Interviews
19.1.2 Industry Databases
19.1.3 Associations
19.1.4 Company News
19.1.5 Company Annual Reports
19.1.6 Application Trends
19.1.7 New Products and Product database
19.1.8 Company Transcripts
19.1.9 R&D Trends
19.1.10 Key Opinion Leaders Interviews
19.1.11 Supply and Demand Trends